Skip to main content
. 2021 Apr 20;66(10):995–1008. doi: 10.1038/s10038-021-00925-x

Table 2.

Disease-causing variants and CNVs identified in the skeletal ciliopathy cohort

Family Gene Nucleotide Amino acid/mRNA Inheritance Previously reported Genomic coordinates MAF#
Patients with clinical diagnoses of SRPS and ATD
1 DYNC2H1 c.7919 T > C p.(Ile2640Thr) P [41] chr11:g.103070036
c.9865 G > A p.(Asp3289Asn) M [8] chr11:g.103114446 0.000003
c.12602 C > T p.(Ser4201Phe) M VCV000558738.1 ClinVar chr11:g.103327017 0.000169
2 DYNC2H1 c.8003 T > G p.(Val2668Gly) P chr11:g.103070120 0.000009
c.9044 A > G p.(Asp3015Gly) M [42] chr11:g.103091449 0.000774
3 DYNC2H1 c.6910 G > A p.(Ala2304Thr) P [8] chr11:g.103058085 0.000697
c.8444 G > A p.(Ser2815Asn) M chr11:g.103075683
4 DYNC2H1 c.5971 A > T p.(Met1991Leu) M/P [42] chr11:g.103048381
c.11284 A > G p.(Met3762Val) M/P [42] chr11:g.103175330 0.003237
5 DYNC2H1 c.5682_5683del p.(His1896Tyrfs*9) M [43] chr11:g.103046971-2 0.000179
c.5771 A > T p.(Asp1924Val) P chr11:g.103047060
6 DYNC2H1 c.729 T > A p.(Tyr243*) P chr11:g.102987406
c.9044 A > G p.(Asp3015Gly) M [42] chr11:g.103091449 0.000774
7 DYNC2H1 c.1855C > T p.(Gln619*) P chr11:g.102996022 0.000105
c.9044 A > G p.(Asp3015Gly) M [42] chr11:g.103091449 0.000774
8 DYNC2H1 c.2386del p.(Arg796Glyfs*8) M chr11:g.103006489 0.000018
c.10163 C > T p.(Pro3388Leu) P VCV000439631.4 ClinVar chr11:g.103124113 0.000140
9 DYNC2H1 c.624_625delGTinsAA p.(Phe209Ile) P [44] chr11:g.102987301-2 0.000157
c.2574 + 1 G > A p.(?) M chr11:g.103006678
10 DYNC2H1 c.7129 T > G p.(Phe2377Val) M chr11:g.103058304
c.6478-16 G > A r.6477_6478ins6478-14_6478-1 P chr11:g.103055609 0.000018
11 DYNC2H1 c.1306 G > T p.(Glu436*) P [22] chr11:g.102991711
c.11070 G > A r.11044_11116del M chr11:g.103158288 0.000033
12 DYNC2H1 c.1366 C > T p.(Arg456*) P chr11:g.102992106 0.000059
c.3455 T > C p.(Phe1152Ser) M chr11:g.103025332
c.5690 T > C p.(Ile1897Thr) M VCV000864089.1 ClinVar chr11:g.103046979 0.000175
c.8354 C > A p.(Ala2785Glu) M chr11:g.103075593 0.000076
13 C2CD3 c.5227 G > T p.(Gly1743Cys) P [36] chr11:g.73760516 0.000163
c.5267 G > A p.(Gly1756Glu) M [35] chr11:g.73760476 0.000062
14 KIAA0753 c.810 C > T r.719_825del M/P chr17:g.6528090 0.000296
15 KIAA0753 c.810 C > T r.719_825del M/P chr17:g.6528090 0.000296
16 KIAA0753 c.970 C > T p.(Arg324*) M/P [12] chr17:g.6526336 0.000033
17 TTC21B c.2758-2 A > G p.(?) M [12, 39] chr2:g.166756392 0.000039
c.3857 T > C p.(Ile1286Thr) P chr2:g.166732691 0.000028
18 WDR19 c.56 T > G p.(Phe19Cys) M chr4:g.39187395 0.000029
c.3868_3871del p.(Thr1290Cysfs*14) P chr4:g.39279778-81 0.000019
19 WDR19 c.974 T > C p.(Leu325Ser) P chr4:g.39217473
c.3758 G > A p.(Cys1253Tyr) M chr4:g.39278681 0.000065
20 IFT74 NC_000009.11: g.26959922_26962969delinsTTA r.-19_120del M/P
Patient with a clinical diagnosis of CED
21 WDR19 c.1623C > G p.(Tyr541*) NA chr4:g.39226647 0.000043
c.3533 G > A p.(Arg1178Gln) NA [45] chr4:g.39274649 0.000388
Patients with clinical diagnoses of EVC
22 EVC c.1018 C > T p.(Arg340*) P [46] chr4:g.5749953 0.000138
c.175-9 G > A r.174_175ins175-7_175-1 M chr4:g.5720966 0.000062
23 EVC2 c.571 A > G p.(Asn191Asp) M/P chr4:g.5691019
24 PRKACA c.409 G > A p.(Gly137Arg) de novo [14] chr19:g.14211648
Patients with unclassified skeletal ciliopathies
25 DYNC2H1 c.10022 C > G p.(Pro3341Arg) P chr11:g.103116062
NC_000011.10: g.103016481_103177263del p.(Ser901Argfs*1?) M
26 NC_000001.11: g.169095250_175778910del 1q24q25 deletion de novo [40]

–, absent; #, gnomAD v2.1.1 and gnomAD v2 SVs

Reference sequences and genomic coordinates according to hg19 [GRCh37]: C2CD3 (NM_015531.5), DYNC2H1 (NM_001080463.1), EVC (NM_001306090.1), EVC2 (NM_147127.4), IFT74 (NM_025103.2), KIAA0753 (NM_014804.2), PRKACA (NM_002730.4); TTC21B (NM_024753.5), WDR19 (NM_025132.3)

ATD asphyxiating thoracic dystrophy, CED cranioectodermal dysplasia, chr chromosome, EVC Ellis-van Creveld syndrome, MAF minor allele frequency (Popmax), M maternal, M/P homozygous variant, NA not available, P paternal, SRPS short-rib polydactyly syndrome